
Loading, please wait...

Loading, please wait...

Endocrine transition care represents a critical clinical phase for adolescents and young adults with chronic childhood-onset conditions. Clinicians recognize that this period carries a high risk for loss to follow-up and clinical deterioration. Furthermore, experts agree that a multidisciplinary approach is essential for success. However, practitioners often lack practical guidance for managing specific medical aspects during the handover.
Many pediatric endocrine conditions involve complex genetic or epigenetic etiologies. Adult endocrinologists often find these specific health issues unfamiliar because they lack specialized training in pediatric domains. Consequently, the transition process frequently becomes fragmented. Therefore, this research addresses these gaps by delineating management strategies for both pediatric and adult clinicians.
Effective management requires a structured framework that begins early in adolescence. Additionally, the latest joint guidance emphasizes eleven critical domains, including patient empowerment and formal care coordination. Specifically, pediatricians must prepare patients for self-management, while adult providers should familiarize themselves with childhood-onset trajectories. Moreover, joint clinics and \"warm hand-offs\" can significantly reduce the risk of disengagement.
Clinicians recommend starting transition preparation in early adolescence, typically around age 12 to 14, to build self-management skills gradually.
The main risks include disengagement from healthcare services, poor treatment adherence, and an increased likelihood of acute medical complications or long-term organ damage.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Zacharin M et al. Clinical Challenges in Transition to Adult Care for Young People With Endocrinopathies. Clin Endocrinol (Oxf). 2026 Mar 12. doi: 10.1111/cen.70118. PMID: 41820251.
2. Le Roux E et al. European Society for Paediatric Endocrinology and European Society of Endocrinology Joint Clinical Practice Guidance for Healthcare Transition from Paediatric to Adult Endocrine Care. Horm Res Paediatr. 2026 Feb 19. doi: 10.1159/000550744.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Expert guidance on managing the transition of pediatric endocrine patients to adult care, highlighting clinical strategies and the role of multidisciplinary...
7 months ago

A landmark 12-year longitudinal study highlights significant reductions in opioid prescribing for nonspecific low back pain following clinical guidelines and prescription monitoring systems, emphasizing non-opioid multimodal pain care.
Today

A study in Ultrasound in Obstetrics & Gynecology shows that quantitative vascularization of the anterior fornix/cervix with transvaginal ultrasound reliably identifies placenta accreta spectrum and predicts severe intraoperative hemorrhage, offering vital objective risk stratification.
Today

A landmark study details how an enterprise pediatric remote patient management model expanded from a single cardiology pilot to 16 diverse specialty programs by combining centralized digital operations with specialty clinical leadership.
Yesterday

A breakthrough study shows that 3D-planned corrective osteotomy successfully resolves distal radioulnar joint instability in pediatric diaphyseal forearm malunions. The precise osseous realignment eliminates chronic wrist pain and restores joint function without requiring secondary soft-tissue reconstruction.
Today

Protein O-GlcNAcylation couples cellular nutrient status to vital neuronal functions. This review explores how disrupted O-GlcNAc cycling drives both neurodevelopmental delays and neurodegenerative cascades, positioning metabolic post-translational modifications as therapeutic targets in clinical neurology.
Today